JPRN-UMIN000040969已完成未知
A prospective, multicenter study on the incidence of postoperative bowel obstruction after laparoscopic colorectal cancer surgery using a absorbable adhesion barrier material (INTERCEED) - Balsam CEED study
ippon medical school0 个研究点目标入组 26 人开始时间: 2020年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients for whom Interseed is contraindicated 2) Patients who received previous abdominal surgery (except for appendectomy performed more than 5 years ago). Anterior approach to inguinal hernia surgery is acceptable. 3) Patients deemed ineligible to participate in this study bytheir physicians 4) Patients with cancer recurrence within 2 years will be excluded at the time of statistical analysis. 5) Cases cannot followed for 2 years will be excluded a the time of statistical analysis.
研究者
相似试验
招募中
不适用
A prospective, multicenter study on the incidence of postoperative bowel obstruction after laparoscopic rectal surgery using an adhesion barrier material (Seprafilm)Rectal cancerJPRN-UMIN000046463ippon Medical School275
已完成
不适用
A multicenter prospective study of the incidence of cholecystitis after endoscopic biliary drainage using a novel low axial force covered self-expandable metallic stent in patients with unresectable malignant distal biliary obstructiopatients with unresectable malignant distal biliary obstructionJPRN-UMIN000038209Kitasato University School of Medicine Department of Gastroenterology100
招募中
不适用
A multi-center prospective study on incidence of adenocarcinoma in Japanese patients with Barrett's esophagusBarrett's esophagusJPRN-UMIN000003789Division of Gastroenterology, Tohoku University Hospital100
招募中
不适用
Incidence of tuberculosis for 2 years after contact to patients with multidrug-resistant tuberculosisDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000004Asan Medical Center472
已完成
不适用
A prospective, multiple center trial for incidence and prevention of hepatitis B virus (HBV) reactivation following hematopoietic stem cell transplantation (HSCT)Patients with resolved HBV infection who receive hematopoietic stem cell transplantationJPRN-UMIN000011543Kiminori Kimura66